3.4. Adiponectin
inflammation
INFLAMMATION
At inclusion, no difference in adiponectin levels between the active treatment group and the placebo group could be demonstrated (active: 3.62 µg/mL vs. placebo: 3.70 µg/mL; Validating the results in an ANCOVA analysis, including several covariates influencing inflammation and cardiovascular mortality, a significant relation was shown only with adiponectin at inclusion and with supplementation with selenium and coenzyme Q